NPWTi 挽救感染假体乳房重建的患者报告结局与费用对比
本研究比较负压伤口治疗联合滴注(NPWTi)早期重新置入假体与标准延迟置入方案,用于感染假体乳房重建的挽救治疗。NPWTi 组重新置入更早、患者满意度更高、住院次数更少,但平均费用更高、住院时间更长、手术次数更多。
要点
- NPWTi 可使感染假体更早重新置入(10.3 天 vs 247.45 天)。
- NPWTi 组患者满意度更高、住院次数更少。
- NPWTi 组平均费用更高、住院时间更长、手术次数更多。
核心结论
- NPWTi 组患者满意度更高,新假体置入更早,住院和门诊次数更少。
- 但 NPWTi 组平均费用更高、住院时间更长、手术次数更多。
- 早期假体重新置入可保留皮肤包膜,避免额外自体组织重建的费用与压力。
研究设计与样本
- 回顾性对比研究,NPWTi 组 20 例与延迟重新置入组 20 例。
- NPWTi 组采用 V.A.C. VERAFLO™ 治疗,随后早期重新置入新假体。
- 患者满意度采用 BREAST-Q 问卷评估,费用计算包含手术、住院、检查、抗生素和门诊费用。
主要发现
- NPWTi 组重新置入时间 10.3 ± 2.77 天,非 NPWTi 组 247.45 ± 111.28 天(p<0.001)。
- NPWTi 组平均费用 £14,343.13 ± £2,786.70,非 NPWTi 组 £8,920.31 ± £3,005.73(p<0.001)。
- NPWTi 组住院 11.9 ± 4.1 天、1 次入院,非 NPWTi 组 7.1 ± 5.8 天、2.1 ± 0.3 次入院(p<0.004 和 p<0.001)。
- NPWTi 组手术次数 3.35 ± 0.81,非 NPWTi 组 2.2 ± 0.41(p=0.006)。
- 非 NPWTi 组有 3 例需皮瓣重建。
临床怎么用
- 对感染假体乳房重建,NPWTi 可作为挽救方案以实现早期假体重新置入。
- 需权衡 NPWTi 更高的费用、更长的住院时间和更多手术次数。
- 早期重新置入有助于保留皮肤包膜,减少后续自体组织重建需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Implant loss due to infection is the most devastating complication of implant-based breast reconstruction. The use of negative pressure wound therapy with instillation(NPWTi) for salvage of infected implant-based breast reconstructions has shown promising results allowing early reinsertion of a new implant as an alternative to the current management with delayed reinsertion. This study compares the patient-reported outcome and cost implication of NPWTi to the current management. METHODS: Twenty cases of infected breast implants treated with NPWTi(V.A.C. VERAFLO™ Therapy), followed by early reinsertion of new implants were compared to 20 cases that had delayed reinsertion(non-NPWTi). Patient satisfaction was evaluated using the BREAST-Q questionnaire. The average cost per patient was calculated using total operative expense, cost of inpatient stay, investigations, antibiotics, and outpatient visits. RESULTS: Treatment with NPWTi allowed earlier reinsertion of a new implant (NPWTi: 10.3 ± 2.77days vs. non-NPWTi: 247.45±111.28days, p<0.001). Patients in the NPWTi group reported higher satisfaction. The average cost per patient for NPWTi and non-NPWTi was £14,343.13±£2,786.70 and £8,920.31±£3,005.73, respectively(p<0.001). All patients treated with NPWTi had one admission and spent 11.9 ± 4.1days as inpatients, while non-NPWTi patients had 2.1 ± 0.3 admissions(p<0.001) and spent 7.1 ± 5.8days(p<0.004) as inpatients. Patients treated with NPWTi had more procedures (NPWTi:3.35±0.81 Vs. non-NPWTi:2.2 ± 0.41, p = 0.006); however, three non-NPWTi cases required flap reconstruction. CONCLUSION: Patients treated with NPWTi reported higher satisfaction, received a new and earlier implant, and had fewer admissions and outpatient visits; however, they incurred higher average costs, longer inpatient stays, and underwent more procedures. Early implant reinsertion preserves skin envelope; hence avoiding additional cost and stress related to further major autologous reconstruction.
引用
- Haque S, Kanapathy M, Bollen E, et al. Patient-reported outcome and cost implication of acute salvage of infected implant-based breast reconstruction with negative pressure wound therapy with Instillation (NPWTi) compared to standard care. J Plast Reconstr Aesthet Surg. 2021. PMID: 34217644. doi:10.1016/j.bjps.2021.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。